• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CAS Investment Partners Sends Letter to At Home Group Stockholders

    6/18/21 9:15:00 AM ET
    $BBBY
    $PRTY
    $CVNA
    $HOME
    Catalog/Specialty Distribution
    Consumer Discretionary
    Diversified Commercial Services
    Miscellaneous
    Get the next $BBBY alert in real time by email

    Holder of 17% of At Home's Common Stock Rejects Hellman & Friedman's Revised Offer of $37 Per Share

    Believes At Home's Sale Process is Tainted by Apparent Conflicts Involving Chairman and CEO Lee Bird, Who Has Been Engaging With Hellman & Friedman Since 2017 and is Set to Retain Meaningful Upside

    Highlights Latest Hellman & Friedman Offer Continues to Dramatically Undervalue At Home's Clear Momentum, Considerable Growth Runway and Significant Margin Expansion Opportunities

    Underscores That a Reasonable Take-Out Price for At Home is $70 Per Share or More

    Urges Fellow Stockholders to Reject the Insufficient and Grossly Undervalued Tender Offer

    CAS Investment Partners, LLC (together with its affiliates, "CAS" or "we"), which beneficially owns approximately 17% of the outstanding common stock of At Home Group Inc. (NYSE:HOME) ("At Home" or the "Company"), today sent the below letter to the Company's stockholders. The letter can also be downloaded at www.ProtectAtHome.com.

    ***

    Dear Fellow Stockholder,

    CAS Investment Partners, LLC (together with its affiliates, "CAS" or "we") holds approximately 17% of the outstanding common stock of At Home Group Inc. ("At Home" or the "Company"), making us the Company's largest stockholder. We focus on conducting fundamental research and making value-oriented investments. We have a successful history of investing in consumer and retail entities that include Carvana Co. (NYSE:CVNA), B&M European Value Retail S.A. (LSE: BME), Herbalife Nutrition Ltd. (NYSE:HLF) and Party City Holdco Inc. (NYSE:PRTY).

    We are writing to you today regarding the proposed sale of At Home to funds advised by Hellman & Friedman LLC (collectively, "H&F"). Based on our thorough analysis of At Home's business and the transaction terms, we have concluded that H&F's original offer of $36 per share and its recently revised offer of $37 per share grossly undervalue the Company and deprive stockholders of meaningful value. We urge you to reject H&F's insufficient tender offer.

    Although we expect At Home's Board of Directors (the "Board") and H&F to dispute our analysis and tout the purported comprehensiveness of their transaction process, we urge you to see through this smokescreen. We believe you should instead focus on one question when considering whether or not to participate in the tender: Is $37 per share fair consideration for a business with clear momentum, a considerable growth runway and significant margin expansion opportunities?

    We devote the rest of this letter to explaining why the answer to this question is clearly "no." We lay out three of our primary conclusions:

    1. At Home's sales process has been flawed from the start and tainted by its Chairman and Chief Executive Officer's apparent incentives to reach a deal with H&F;
    2. The Board's Special Committee seemingly wrote off the Company's past several quarters of tangible business improvements and material progress, and;
    3. The Board's Special Committee discounted the Company's significant future revenue and earnings potential, resulting in an overly-pessimistic valuation.

    If H&F wants to acquire At Home, we believe it should pay a reasonable premium that appropriately reflects the Company's path to enhanced value and the present consumer environment. It is disturbing that the Board's Special Committee is trying to usher through a fire sale just as At Home is gaining considerable momentum and the pandemic's economic overhang is subsiding. At Home, which can become the next great American retailer, has the ability to grow rapidly and produce tremendous value for stockholders in the public market.

    STOCKHOLDERS SHOULD CLOSELY SCRUTINIZE THE BOARD'S SALE PROCESS AND MR. BIRD'S APPARENT CONFLICTS OF INTEREST.

    At Home's Board formed its Special Committee in December 2020, when the COVID-19 pandemic was continuing to wreak havoc over the U.S. economy and retailers still faced material uncertainty. A simple review of At Home's financial results and stock price volatility over the course of 2020 underscores just how much the pandemic impacted the Company's business and valuation last year. This is why we continue to seriously question whether late 2020 was even an appropriate time to explore a sale to a financial sponsor known to pursue low-multiple transactions.

    As At Home's business has recovered and begun to achieve momentum during the first half of 2021, it appears the Special Committee and its advisors failed to sufficiently account for the Company's sustained progress when negotiating with H&F. In March 2021, At Home reported fourth quarter sales that included a 41% net sales increase and a 30.8% comparable store sales increase.1 The Company also reported record-setting fourth quarter net income of $72.7 million.2 This momentum has continued into fiscal year 2022 with the Company reporting first quarter sales of $537 million, the second highest quarterly sales in the Company's history and up 75.4% compared to the first quarter of fiscal year 2020. [Third party credit card data indicates the Company's strong sales trends are continuing into the second quarter.]

    While the Special Committee secured several price bumps (albeit insufficient) to increase H&F's bid, we feel there is nothing for stockholders to celebrate. We question how the Special Committee and its advisors could even consider a "best and final" $37 per share bid to be sufficient when At Home's shares were already trading around $30 per share before reporting excellent earnings in March. Moreover, long-term stockholders can no doubt recall that the Company's stock price was trading above $37 per share at this time three years ago – well in advance of material and permanent improvements achieved in the intervening period.

    It seems clear to us that At Home's leadership is all too eager to enter into a transaction with H&F. This is especially concerning when taking into account that the Board did not announce and carry out a comprehensive review of strategic alternatives prior to falling into H&F's arms this spring or otherwise attempt to reach out and seek the support of key stockholders, including CAS. Instead, it formed the Special Committee last year to take over discussions that had been occurring between H&F and the Company's Chairman and Chief Executive Officer, Lee Bird, since 2017.

    We feel At Home's proxy materials paint a very troubling picture of Mr. Bird's frequent conversations with H&F over the years. It is not surprising to us that At Home was not receiving interest from other sponsors and strategic buyers when Mr. Bird was consistently engaging with H&F. Our experience suggests that this type of interaction between a corporate executive and potential acquirer can have a chilling effect on other parties' interest in a potential transaction.

    Unlike stockholders, who would likely leave a lot of value on the table under the current deal, it is important to understand that Mr. Bird stands to be handsomely rewarded if At Home is sold to H&F:3

    • Mr. Bird will receive over $100 million of estimated consideration in connection with the merger;
      • Approximately $72 million on account of common equity holdings and vested stock options;
      • Approximately $15 million from the accelerated vesting of certain stock options and PSUs, and;
      • The conversion of approximately $14 million of long-vesting equity awards to RCAs, which eliminates any performance-based vesting conditions;
    • Mr. Bird will continue to serve as Chairman and Chief Executive Officer;
    • Mr. Bird will receive a new employment agreement with very favorable equity vesting and payment terms;
    • Mr. Bird will receive stock options representing approximately 4% of the fully diluted shares through the 10% option pool; and
    • Mr. Bird will roll over $10 million of equity and may have other favorable optionality on converting securities granted to him.

    Given the substantial compensation and benefits Mr. Bird is set to receive under the proposed sale and his continuous dealings with H&F, we believe the sales process was flawed and riddled with conflict. We anticipate that At Home will try to deflect attention away from our concerns by highlighting its 40-day "go-shop" process, but the reality is that these processes have become an increasingly ineffective check on a bad deal. A 2020 analysis in the Harvard Law Review notes that "go-shops, in general, are no longer an effective tool for post-signing price discovery."4 The authors of the analysis "document several reasons for this change: the proliferation of first-bidder match rights, the shortening of go-shop windows, CEO conflicts of interest, investment banker effects, and collateral terms that have the effect of tightening the go-shop window."5 An after the fact "go shop" does not change the fact that this transaction was not the result of a full and fair sale process to maximize value for all At Home stockholders.

    STOCKHOLDERS SHOULD CHALLENGE THE SPECIAL COMMITTEE'S OVERLY-PESSIMISTIC VALUATION OF AT HOME.

    Based on our most conservative analysis of the proposed sale, H&F's implied purchase price is only 12.9x the underlying earnings power of the current and immediately planned store base for fiscal year 2023.6 This valuation seems to assume something that is quite implausible: (i) the store base only grows to 250 (the average planned for fiscal year 2023) without any subsequent growth and (ii) all gains across At Home's operations and competitive position between fiscal year 2019 and Q1 fiscal year 2022 reverse by fiscal year 2023. Under this extraordinarily pessimistic scenario, At Home's revenue per store will have regressed to its prior trendline of $7.5 million per store (vs. $9.4 million per store during the LTM period) and the Company's adjusted EBIT margins – excluding store opening expenses – will have dipped back to fiscal year 2019 levels of approximately 13.1%.7 It is utterly confounding that fiduciaries with an obligation to maximize value for At Home stockholders would accept this type of valuation.

    In our view, a far more realistic valuation could be determined by assuming At Home can return to approximately 20% store growth in fiscal year 2023. As a result of keeping some of the gains from fiscal year 2021 and building upon those in the subsequent years, we now believe the Company can achieve $8.5 million in sales per store and 14% EBIT margins – net of pre-opening expenses – by fiscal year 2027. Under this scenario and operating without financial leverage, we estimate the Company's earnings can grow to approximately $6.748 per share by fiscal year 2027.

    We contend that by fiscal year 2026, the market could value At Home at 20x forward profits or even more given the following tailwinds:

    • The Company's unlevered balance sheet;
    • The further remaining opportunity to continue expanding to 600+ stores;
    • The potential to expand revenue per store to $10 million plus, and;
    • The potential to further expand margins going forward.

    In light of this, we estimate that At Home's stock would be worth more than $135 per share by the end of fiscal 2026, which is less than five years from now. Discounting this $135 back five years at the conservative rate of 13% yields a fair take-out value of $70 per share or more today.

    With all this context in mind, we feel stockholders could do even better than this scenario and receive a substantial distribution immediately if the Company were to leverage its balance sheet in the manner H&F plans to do. This is why we do not intend to tender our stock and will continue to vehemently oppose this grossly undervalued transaction.

    STOCKHOLDERS SHOULD QUESTION THE SPECIAL COMMITTEE'S DECISION TO WRITE-OFF THE COMPANY'S RECENT IMPROVEMENTS.

    In addition to apparently discounting At Home's most recent quarterly earnings progress, it seems the Special Committee also wrote off numerous business improvements when negotiating with H&F. Stockholders should recall that the Company's own presentations and filings have laid out the following developments in recent years:

    • Millions of consumers have discovered At Home based on unaided brand awareness increasing from 15% to 19% over the course of fiscal year 2021.
    • The Company's Insider Perks loyalty program, which had zero members in August 2017, grew by approximately 2.6 million to approximately 9.1 million members over the course of fiscal year 2021.
    • The Company has gone from a non-existent e-commerce presence in fiscal year 2019 to a robust one that now enables customers to execute online purchases and arrange for in-store pick-up or direct delivery.
    • The Company substantially improved the merchandizing of its unique offering with the introduction of EDLP+.
    • The Company has expanded its direct sourcing from practically nothing in fiscal 2018 to 15% at the end of fiscal 2020 to nearly 20% at the end of fiscal 2021, thereby driving hundreds of basis points of margin improvement on each item sourced directly while enhancing product quality.
    • The Company's growing store footprint and larger customer base has increased its purchasing scale and corporate leverage.
    • Many of the company's competitors have reduced their store footprints or permanently shuttered, including Bed Bath & Beyond (NASDAQ:BBBY), Pier 1 Imports, Inc. and Penney OpCo LLC's JC Penney.

    We find it extremely curious that At Home promoted many of these developments in recent years, only to then apparently discount them when reaching a deal.

    THE CHOICE SHOULD BE CLEAR: REJECT THE H&F TENDER.

    We know we are not alone in opposing this insufficient, conflict-ridden deal. It has been encouraging to receive unsolicited feedback from many other stockholders who share our view about At Home's long-term prospects. As noted, we truly believe the Company can become the next great American retailer as the pandemic fades and the housing economy thrives.

    In the coming days and weeks, CAS will continue to share our analysis and views regarding this flawed sale. We are committed to continuing to demonstrate that it is in stockholders' best interest to reject the H&F tender. At Home's decision to pivot to a tender offer seems like recognition that the deal would have likely been voted down. We believe this only further proves how imperative it is that stockholders do not tender into this grossly undervalued price. We will not sit by as At Home gets taken private on terms that would benefit H&F and the Company's insiders far more than stockholders.

    Sincerely,

    Clifford A. Sosin

    Founder and Portfolio Manager

    CAS Investment Partners, LLC

    ***

    About CAS Investment Partners, LLC

    CAS Investment Partners, LLC is a value-focused investment management firm with offices in New York City and Connecticut. The firm was founded in 2012 by Clifford A. Sosin.


    1 Press release entitled "At Home Group Inc. Announces Fourth Quarter Fiscal 2021 Financial Results" issued on March 23, 2021.

    2 Press release entitled "At Home Group Inc. Announces Fourth Quarter Fiscal 2021 Financial Results" issued on March 23, 2021.

    3 Company filings (bullets pertaining to Mr. Bird's compensation reflect a $36 per share sale price).

    4 Harvard Law Review, "Go-Shops Revisited," February 10, 2020.

    5 Harvard Law Review, "Go-Shops Revisited," February 10, 2020.

    6 CAS analysis excludes pre-opening store expenses.

    7 CAS FY 2019 adjusted EBIT excluding store opening expenses as follows: Adjusted EBITDA of $191,245 plus costs associated with new store openings of $18,656, minus stock based compensation expense of $5,530 minus depreciation and amortization $56,529 equals Adj EBIT ex preopening expense of $153,003, which divided by $1,165,899 of sales yields a 13.1% margin.

    8 Based on 67,293,430 fully diluted shares of Common Stock outstanding as of January 30, 2021.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210618005314/en/

    Get the next $BBBY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BBBY
    $PRTY
    $CVNA
    $HOME

    CompanyDatePrice TargetRatingAnalyst
    Herbalife Ltd.
    $HLF
    1/6/2026$20.00Buy
    Maxim Group
    Carvana Co.
    $CVNA
    12/15/2025$500.00Buy
    Argus
    Carvana Co.
    $CVNA
    12/1/2025$450.00Buy
    UBS
    Herbalife Ltd.
    $HLF
    11/26/2025Hold → Buy
    Argus
    Carvana Co.
    $CVNA
    11/24/2025$400.00Neutral → Outperform
    Wedbush
    Carvana Co.
    $CVNA
    11/21/2025$395.00Buy
    Deutsche Bank
    Carvana Co.
    $CVNA
    11/12/2025$390.00Overweight
    Barclays
    Carvana Co.
    $CVNA
    10/21/2025$425.00 → $490.00Overweight
    Analyst
    More analyst ratings

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carvana Board of Directors Approves 5 for 1 Forward Stock Split

    Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced that its Board of Directors approved a 5 for 1 split of its common stock. The split is designed to ensure that earning and buying whole shares of Carvana stock is within reach for all of its team members. "This is the first split in Carvana's history, and we believe it achieves the important goal of keeping our stock accessible to all of our team members," said Mark Jenkins, Chief Financial Officer of Carvana. "This decision follows significant stock appreciation as Carvana reached new all-time records for units and profitability while continuing to lead the industry in growth in 2025." Carvana

    3/13/26 9:05:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Carvana Expands Same-Day Delivery to Los Angeles

    Local car buyers and sellers now have access to faster, more convenient service Carvana (NYSE:CVNA), an industry pioneer for buying and selling cars online, today announced the expansion of same-day vehicle delivery for customers in the greater Los Angeles area. Select local customers can now receive their vehicle as soon as the same day they place an order on Carvana.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311300577/en/Carvana Expands Same-Day Delivery to Los Angeles. With this launch, Los Angeles-area customers interested in selling their vehicles to Carvana can also take advantage of same-day pickup and drop-

    3/11/26 9:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    $BBBY
    $PRTY
    $CVNA
    $HOME
    SEC Filings

    View All

    SEC Form DEFA14A filed by Carvana Co.

    DEFA14A - CARVANA CO. (0001690820) (Filer)

    3/13/26 9:05:16 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form PRE 14A filed by Carvana Co.

    PRE 14A - CARVANA CO. (0001690820) (Filer)

    3/13/26 9:01:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form S-8 filed by Bed Bath & Beyond Inc.

    S-8 - BED BATH & BEYOND, INC. (0001130713) (Filer)

    3/11/26 5:25:17 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Argus initiated coverage on Carvana with a new price target

    Argus initiated coverage of Carvana with a rating of Buy and set a new price target of $500.00

    12/15/25 8:51:06 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    UBS initiated coverage on Carvana with a new price target

    UBS initiated coverage of Carvana with a rating of Buy and set a new price target of $450.00

    12/1/25 8:27:27 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by President & CFO Lee Adrianne

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 6:57:02 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Chief Accounting Officer Putnam Leah R

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 6:19:15 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Leadership Updates

    Live Leadership Updates

    View All

    Bed Bath & Beyond Appoints Nora Gomez as Chief Merchandising Officer

    Strategic hire strengthens focus on growth, margin expansion, and whole-home execution entering 2026 MURRAY, Utah and NASHVILLE, Tenn., Dec. 9, 2025 /PRNewswire/ -- Bed Bath & Beyond, Inc. (NYSE:BBBY) and The Brand House Collective, Inc. (NASDAQ:TBHC) today announced that Nora Gomez has been appointed Chief Merchandising Officer for Bed Bath & Beyond and its family of brands, driving unified product strategy and accountability across the entire portfolio. Gomez is a proven retail leader with over 20 years of experience in assortment strategy, global sourcing, and multi-channel

    12/9/25 7:30:00 AM ET
    $BBBY
    $TBHC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Bed Bath & Beyond Appoints Rick Lockton as Executive Vice President and Chief Digital, Product, and Technology Officer

    Bed Bath & Beyond, Inc. (NYSE:BBBY) (the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, and a blockchain asset portfolio, today announced the appointment of Rick Lockton as Executive Vice President and Chief Digital, Product, and Technology Officer. Effective November 3, 2025, Lockton will join the executive leadership team to lead the Company's digital transformation and product innovation strategy. He will oversee technology integrations across omnichannel partnerships, blockchain investments, and emerging home technology ventures while maintaining a sharp focus on growing the core online retail business. His priorities include accelerating digital growth, improving con

    10/29/25 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Financials

    Live finance-specific insights

    View All

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    Bed Bath & Beyond, Inc. Reports Eighth Consecutive Quarter of Measurable Improvement Toward Profitability

    Q4 Reflects Strengthening Revenue Trends, Sustained Margin Expansion and a $118 Million Year-Over-Year Improvement in Operating Cash Flow Use Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's Home and a blockchain asset portfolio, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company delivered its eighth consecutive quarter of measurable improvement toward profitability, reflecting continued margin expansion, disciplined cost management and consistent progress across key operating metrics. The Company has successfully built the base of its business through disciplined retail executio

    2/23/26 4:01:00 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance

    Cristiano Ronaldo Invests $7.5 Million in Herbalife's Pro2col™ Technology Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218518159/en/ "We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo's investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions." - Stephan Gratziani, CEO Hi

    2/18/26 4:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $BBBY
    $PRTY
    $CVNA
    $HOME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Carvana Co.

    SC 13G/A - CARVANA CO. (0001690820) (Subject)

    11/14/24 5:58:14 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Carvana Co.

    SC 13G/A - CARVANA CO. (0001690820) (Subject)

    11/14/24 4:30:57 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary